Susquehanna International Group’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Buy |
306,069
+49,286
| +19% | +$171K | ﹤0.01% | 3155 |
|
|
2025
Q1 | $673K | Buy |
256,783
+180,465
| +236% | +$473K | ﹤0.01% | 3942 |
|
|
2024
Q4 | $314K | Buy |
76,318
+33,930
| +80% | +$140K | ﹤0.01% | 4704 |
|
|
2024
Q3 | $300K | Sell |
42,388
-12,003
| -22% | -$85K | ﹤0.01% | 4299 |
|
|
2024
Q2 | $355K | Sell |
54,391
-9,329
| -15% | -$60.8K | ﹤0.01% | 4006 |
|
|
2024
Q1 | $529K | Buy |
63,720
+26,082
| +69% | +$216K | ﹤0.01% | 3466 |
|
|
2023
Q4 | $414K | Sell |
37,638
-177,137
| -82% | -$1.95M | ﹤0.01% | 4109 |
|
|
2023
Q3 | $1.81M | Buy |
214,775
+155,358
| +261% | +$1.31M | ﹤0.01% | 1927 |
|
|
2023
Q2 | $746K | Sell |
59,417
-195,480
| -77% | -$2.46M | ﹤0.01% | 3100 |
|
|
2023
Q1 | $4.2M | Buy |
254,897
+218,782
| +606% | +$3.6M | ﹤0.01% | 1227 |
|
|
2022
Q4 | $540K | Sell |
36,115
-69,038
| -66% | -$1.03M | ﹤0.01% | 3104 |
|
|
2022
Q3 | $2.35M | Buy |
105,153
+19,916
| +23% | +$445K | ﹤0.01% | 1515 |
|
|
2022
Q2 | $1.43M | Buy |
85,237
+10,357
| +14% | +$174K | ﹤0.01% | 2044 |
|
|
2022
Q1 | $2.24M | Sell |
74,880
-19,514
| -21% | -$584K | ﹤0.01% | 1897 |
|
|
2021
Q4 | $2.9M | Buy |
94,394
+39,328
| +71% | +$1.21M | ﹤0.01% | 1623 |
|
|
2021
Q3 | $1.74M | Buy |
55,066
+20,033
| +57% | +$632K | ﹤0.01% | 2111 |
|
|
2021
Q2 | $1.28M | Sell |
35,033
-47,966
| -58% | -$1.76M | ﹤0.01% | 2643 |
|
|
2021
Q1 | $2.87M | Buy |
82,999
+71,228
| +605% | +$2.46M | ﹤0.01% | 1734 |
|
|
2020
Q4 | $489K | Buy |
+11,771
| New | +$489K | ﹤0.01% | 3436 |
|